Fracture prevention in patients with cognitive impairment presenting with a hip fracture: secondary analysis of data from the HORIZON Recurrent Fracture Trial

[1]  L. Lix,et al.  Competing mortality and fracture risk assessment , 2013, Osteoporosis International.

[2]  Gordon H Guyatt,et al.  Credibility of claims of subgroup effects in randomised controlled trials: systematic review , 2012, BMJ : British Medical Journal.

[3]  A. Oxman.  Subgroup analyses , 2012, BMJ : British Medical Journal.

[4]  L. Fratiglioni,et al.  Undertreatment of osteoporosis in persons with dementia? A population-based study , 2012, Osteoporosis International.

[5]  C. Cooper,et al.  Osteoporosis: burden, health care provision and opportunities in the EU , 2011, Archives of osteoporosis.

[6]  S. Boonen,et al.  Coordinator-based systems for secondary prevention in fragility fracture patients , 2011, Osteoporosis International.

[7]  C. Moran,et al.  Nottingham Hip Fracture Score as a predictor of one year mortality in patients undergoing surgical repair of fractured neck of femur. , 2011, British journal of anaesthesia.

[8]  M. Safford,et al.  Is withholding osteoporosis medication after fracture sometimes rational? A comparison of the risk for second fracture versus death. , 2010, Journal of the American Medical Directors Association.

[9]  Douglas P Kiel,et al.  Competing Risk of Death: An Important Consideration in Studies of Older Adults , 2010, Journal of the American Geriatrics Society.

[10]  Xin Sun,et al.  Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses , 2010, BMJ : British Medical Journal.

[11]  M. Tinetti,et al.  The patient who falls: "It's always a trade-off". , 2010, JAMA.

[12]  S. Boonen,et al.  Potential mediators of the mortality reduction with zoledronic acid after hip fracture , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[13]  Emma Smith,et al.  Recurrent and injurious falls in the year following hip fracture: a prospective study of incidence and risk factors from the Sarcopenia and Hip Fracture study. , 2009, The journals of gerontology. Series A, Biological sciences and medical sciences.

[14]  C. Moran,et al.  Development and validation of a preoperative scoring system to predict 30 day mortality in patients undergoing hip fracture surgery. , 2008, British journal of anaesthesia.

[15]  S. Boonen,et al.  Zoledronic acid and clinical fractures and mortality after hip fracture. , 2007, The New England journal of medicine.

[16]  J. Hirdes,et al.  Factors associated with pharmacologic treatment of osteoporosis in an older home care population. , 2007, The journals of gerontology. Series A, Biological sciences and medical sciences.

[17]  I. Mühlhauser,et al.  Risedronate for the prevention of hip fractures: concern about validity of trials. , 2007, Archives of internal medicine.

[18]  D. Marsh,et al.  Outcome Following Proximal Femoral Fracture in Northern Ireland , 2006, The Ulster medical journal.

[19]  J. Iwamoto,et al.  The prevention of hip fracture with risedronate and ergocalciferol plus calcium supplementation in elderly women with Alzheimer disease: a randomized controlled trial. , 2005, Archives of internal medicine.

[20]  Douglas G Altman,et al.  Interaction revisited: the difference between two estimates , 2003, BMJ : British Medical Journal.

[21]  K. Carriere,et al.  Functional Dependence After Hip Fracture , 2001, American journal of physical medicine & rehabilitation.

[22]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[23]  A. Lusky,et al.  Cognitive status at admission: does it affect the rehabilitation outcome of elderly patients with hip fracture? , 1999, Archives of physical medicine and rehabilitation.

[24]  J. Mucklow,et al.  Studies of the oral bioavailability of alendronate , 1995, Clinical pharmacology and therapeutics.

[25]  A. Galecki,et al.  Identifying elderly patients for early discharge after hospitalization for hip fracture. , 1993, Journal of gerontology.

[26]  D. Wood,et al.  Factors which influence mortality after subcapital hip fracture. , 1992, The Journal of bone and joint surgery. British volume.

[27]  R. Sulkava,et al.  Short Portable Mental Status Questionnaire as a Screening Test for Dementia and Delirium Among the Elderly , 1987, Journal of the American Geriatrics Society.

[28]  D. Elmqvist,et al.  Cardiovascular and neurological function in elderly patients sustaining a fracture of the neck of the femur. , 1981, The Journal of bone and joint surgery. British volume.

[29]  D. Prudham,et al.  A prospective study of fractured proximal femur: factors predisposing to survival. , 1979, Age and ageing.

[30]  E. Pfeiffer.  A Short Portable Mental Status Questionnaire for the Assessment of Organic Brain Deficit in Elderly Patients † , 1975, Journal of the American Geriatrics Society.

[31]  J. Ide,et al.  Prediction of postoperative ambulatory status 1 year after hip fracture surgery. , 2010, Archives of physical medicine and rehabilitation.

[32]  S. Berney,et al.  Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis , 2008 .